975 A phase I/II single arm trial to determine the safety, tolerability, and biological activity of intrahepatic delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers (MTC-DOX) in patients with metastatic tumors in the liver

Authors:
  • RJR. Just
    R. Just
  • CHC. Hoh
    C. Hoh
  • TVT. Vogl
    T. Vogl
  • PNP. Neese
    P. Neese
  • JDJ. Doemeny
    J. Doemeny
  • MSM. Schechter
    M. Schechter
  • RVR. Varney
    R. Varney
  • WSW. Stanton
    W. Stanton
  • MSM. Schiemann
    M. Schiemann
  • PGP. Goldfarb
    P. Goldfarb
Publisher website
Google Scholar
Abstract
No abstract available